2. GPCR/G Protein Neuronal Signaling
  3. Amylin Receptor CGRP Receptor
  4. KBP-336

KBP-336 is a dual amylin and calcitonin receptor agonist (DACRA). KBP-336 exhibits antidiabetic and insulin-sensitizing properties, improves glucose levels, spatial learning, and memory in diabetic rats, and reduces blood glucose. KBP-336 also alleviates pain-like symptoms in osteoarthritis rats. KBP-336 also promotes weight and fat reduction. KBP-336 is useful for research on diabetes, obesity, and arthritis.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

Synthèse de peptides personnalisée

KBP-336

KBP-336 Chemical Structure

Size Stock
50 mg   Obtenir un devis  
100 mg   Obtenir un devis  
250 mg   Obtenir un devis  

* Veuillez sélectionner la quantité avant d'ajouter des articles.

This product is a controlled substance and not for sale in your territory.

KBP-336 Related Antibodies

Top Publications Citing Use of Products

  • Activité biologique

  • Pureté et documentation

  • Références

  • Avis client

Description

KBP-336 is a dual amylin and calcitonin receptor agonist (DACRA). KBP-336 exhibits antidiabetic and insulin-sensitizing properties, improves glucose levels, spatial learning, and memory in diabetic rats, and reduces blood glucose. KBP-336 also alleviates pain-like symptoms in osteoarthritis rats. KBP-336 also promotes weight and fat reduction. KBP-336 is useful for research on diabetes, obesity, and arthritis[1][2][3].

In Vivo

KBP-336 (4.5 nmol/kg; subcutaneous injection; once every 3 days; 127 days) improves spatial learning and memory deficits and hyperglycemia in diabetic rats and prevents the development of ocular cataracts[1].
KBP-336 (0.5-4.5 nmol/kg; subcutaneous injection; every 72 hours; 6-8 weeks) alleviates pain-like symptoms and reduces body weight and adipose tissue in rats with high-fat diet-induced obesity combined with medial meniscectomy[2].
KBP-336 (4.5 nmol/kg; subcutaneous injection; once every 3 days; 8 weeks) exhibits anti-obesity activity in high-fat diet-induced obese rats[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Zucker Diabetic Fatty Rats (male, 6-7 weeks old, fed Purina Laboratory Diet #5008, left untreated for 3 weeks to develop diabetes)[1]
Dosage: 4.5 nmol/kg
Administration: s.c.; every 3 days; 127 days
Result: Significantly improved spatial learning.
Improved fasting blood glucose levels, reduced tAUC of fasting blood glucose and improved HbA1c levels.
Improved glucose tolerance, preserved plasma insulin levels and prevented eye cataract development.
Animal Model: Sprague Dawley rats (high-fat diet-fed with medial meniscectomy)[2]
Dosage: 0.5 nmol/kg; 1.5 nmol/kg; 4.5 nmol/kg
Administration: s.c.; every 72 hours; 6 and 8 weeks
Result: Significantly increased the 50% paw withdrawal threshold (PWT), indicating relieved pain-like symptoms.
Induced significant weight loss and reduced inguinal and perirenal adipose tissue masses at doses of 1.5 and 4.5 nmol/kg.
Did not affect body weight or fat depots, still effectively alleviated pain at 0.5 nmol/kg dose.
Animal Model: Sprague-Dawley rats (male, 5-6 weeks, high-fat diet)[3]
Dosage: 4.5 nmol/kg
Administration: s.c.; every 3 days; 8 weeks
Result: Significantly reduced body weight and adiposity, improved glucose homeostasis, delayed gastric emptying.
Increased oligomycininduced leak respiration and the activity of citrate synthase and β-hydroxyacetyl-CoA-dehydrogenase.
Masse moléculaire

3917.50

Formule

C172H287N43O56S2
Sequence

Ac-Cys-Ala-Ser-Leu-Ser-Thr-Cys-{Aib}-Leu-Gly-Arg-Leu-Ser-Ala-Glu-Leu-His-Lys(AEEA-AEEA-γGlu-C18 diacid)-Ala-Thr-Tyr-Pro-Lys-Thr-Asp-Val-Gly-Ala-Asn-Ala-Pro-NH2
Sequence Shortening

Ac-CASLSTC-{Aib}-LGRLSAELH-Lys(AEEA-AEEA-γGlu-C18 diacid)-ATYPKTDVGANAP-NH2
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage

Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

KBP-336 Related Classifications

  • Calculateur de molarité

  • Calculateur de dilution

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

KBP-336KBP336KBP 336Amylin ReceptorCGRP ReceptorAMYRCalcitonin gene-related peptide receptorbody weightantinociceptionZucker Diabetic Fatty ratsdiabetesobesityInhibitorinhibitorinhibit

Vos produits récemment consultés:

Demande en ligne

Your information is safe with us. * Required Fields.

Nom du produit

  

Requested Quantity *

Nom du demandeur *

 

Civilité

Adresse e-mail *

 

Numéro de téléphone *

Department

 

Nom de l'organisation *

City

État

Country or Region *

      

Remarques

Bulk Inquiry

Inquiry Information

Nom du produit:
KBP-336
Cat. No.:
HY-P11629
Quantité:
MCE Japan Authorized Agent:

Avis client

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Nom du produit

  

Lot #

Nom du demandeur *

 

Adresse e-mail *

Numéro de téléphone

 

Department *

Nom de l'organisation *

 

Country or Region *

Remarques

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.